진공 채혈관 시장 동향, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Vacuum blood collection tube market size is anticipated to grow at a 4.1% CAGR between 2024 and 2032 driven by the surging demand for precise and efficient blood collection methods in healthcare. Vacuum blood collection tubes are preferred for their capability to minimize contamination risks. They utilize a controlled vacuum mechanism to draw blood to ensure accuracy. As global healthcare systems evolve, emphasizing diagnostic precision, the adoption of these tubes becomes increasingly widespread.

The product demand is further amplified by innovations like specialized additives and coatings that enhance sample stability, alongside ergonomic designs for user-friendliness. With chronic diseases on the rise and an increased emphasis on routine screenings, the volume of blood tests is swelling, subsequently driving the consumption of these tubes. Reports further indicate that approximately one in three adults grapple with chronic ailments.

The industry is divided into product type, material, application, end user, and region.

Based on product type, the vacuum blood collection tube market size from the EDTA tubes segment is poised to grow between 2024 and 2032 backed by their critical role in blood sampling for hematological tests. EDTA, an anticoagulant, prevents blood clotting and preserves cellular components, making it essential for accurate blood cell counts and other hematology tests.

Vacuum blood collection tube market from the coagulation tests application segment is set to witness a significant CAGR from 2024 to 2032. This surge is attributed to the essential role of tubes in delivering reliable results for clotting evaluations. Coagulation assessments mandate specific tubes with anticoagulants to ensure sample stability and prevent clotting.

Asia Pacific vacuum blood collection tube industry is expected to accrue notable expansion from 2024 to 2032. Rapid urbanization, rising healthcare expenditures, and the growing prevalence of chronic diseases in APAC countries contribute to a higher volume of blood tests and diagnostic procedures. The expansion of healthcare facilities, coupled with the higher adoption of modern diagnostic practices, further supports the market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic and infectious diseases
    • 3.2.1.2 Growing number of blood transfusions
    • 3.2.1.3 Rise in the number of surgical procedures and accidents
    • 3.2.1.4 Increasing number of diagnostic centers and laboratories across the globe
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulations for the disposal of the tubes
    • 3.2.2.2 Risk of contamination and hemolysis
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Serum separating tubes
  • 5.2.1 Silica
  • 5.2.2 Thrombin
• 5.3 Plasma separation tubes
• 5.4 EDTA tubes
• 5.5 Rapid serum tubes
• 5.6 Coagulation tubes
• 5.7 Other product types

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 PET/Plastic
• 6.3 Glass

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Serology and immunology
• 7.3 Blood routine examination
• 7.4 Coagulation tests
• 7.5 Genetic studies
• 7.6 Blood sugar assay
• 7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Pathology laboratories
• 8.4 Blood banks
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 AdvaCare Pharma
• 10.2 Advin Health Care
• 10.3 Becton, Dickinson and Company
• 10.4 Biota
• 10.5 Cardinal Health, Inc.
• 10.6 Chengdu Rich Science Industry Co., Ltd.
• 10.7 FL MEDICAL s.r.l.
• 10.8 Greiner Bio-One International GmbH
• 10.9 Hindustan Syringes and Medical Devices Ltd
• 10.10 IntervacTechnology
• 10.11 MB Plastic Industries
• 10.12 Poly Medicure Ltd.
• 10.13 SEKISUI CHEMICAL CO., LTD.
• 10.14 Streck
• 10.15 Zhejiang Gongdong Medical Technology Co., Ltd.